Literature DB >> 10319421

Lipoprotein alterations, abdominal fat distribution and breast cancer.

L E Schreier1, G A Berg, F M Basilio, G I Lopez, A E Etkin, R L Wikinski.   

Abstract

Plasma lipid profile and abdominal obesity have been associated with breast cancer risk, however published results have been inconsistent. To clarify these associations we studied lipid and lipoprotein alterations, obesity degree and body fat distribution, in 30 newly diagnosed breast cancer patients without treatment and 30 controls matched by age and menopausal status. Both pre and postmenopausal breast cancer patients presented higher body mass index, waist/hip ratio and insulin levels than their matched controls. An increase in triglycerides and a decrease in HDL-cholesterol, especially in the HDL2 subfraction, were observed in patients with breast cancer. Besides, HDL particle from these patients showed increased apo A1/HDL-cholesterol ratio. These alterations were correlated with waist/hip ratio. The association between lipoprotein alterations and abdominal obesity independent of menopausal status, in untreated newly diagnosed breast cancer patients is reported for the first time in this study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319421     DOI: 10.1080/15216549900201743

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  8 in total

1.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

2.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan.

Authors:  Padmanabh Inamdar; Garima Mehta
Journal:  Indian J Surg Oncol       Date:  2011-05-06

4.  Alterations of serum cholesterol and serum lipoprotein in breast cancer of women.

Authors:  Kiran Hasija; Hardeep K Bagga
Journal:  Indian J Clin Biochem       Date:  2005-01

5.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

Review 6.  Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?

Authors:  Carmelita Abrahams; Nicholas J Woudberg; Sandrine Lecour
Journal:  Lipids Health Dis       Date:  2022-09-01       Impact factor: 4.315

7.  The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan - a cross-sectional study.

Authors:  Zhi-Hong Jian; Chia-Chi Lung; Pei-Chieh Ko; Yi-Hua Sun; Jing-Yang Huang; Chien-Chang Ho; Chia-Yo Ho; Yi-Chen Chiang; Chien-Jen Chen; Yung-Po Liaw
Journal:  BMC Endocr Disord       Date:  2013-10-07       Impact factor: 2.763

8.  Metabolic Syndrome and Breast Cancer Risk.

Authors:  Burhan Wani; Shiekh Aejaz Aziz; Mohammad Ashraf Ganaie; Mohammad Hussain Mir
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.